Global Epilepsy Monitoring Devices Market Size Study & Forecast, by Product (Wearable Devices, Conventional Devices), End-use (Neurology Centers, Diagnostic Centers), and Regional Forecasts 2025-2035

The Global Epilepsy Monitoring Devices Market is valued at approximately USD 0.59 billion in 2024 and is anticipated to grow at a CAGR of more than 6.60% over the forecast period 2025-2035. Epilepsy monitoring devices have emerged as indispensable tools for clinicians and caregivers, designed to detect, track, and analyze seizure activity with enhanced accuracy and real-time responsiveness. These devices, ranging from conventional hospital-based systems to advanced wearable technologies, help in diagnosing seizure types, monitoring treatment efficacy, and improving patient quality of life. The surging prevalence of epilepsy across the globe, coupled with rising investments in healthcare infrastructure and technological advancements in medical devices, has accelerated the demand for reliable epilepsy monitoring solutions. Moreover, the growing emphasis on personalized care and home-based patient management has spurred adoption of wearable devices that provide continuous monitoring and timely alerts.

The increasing incidence of epilepsy worldwide has triggered a substantial rise in the need for precise monitoring solutions. According to the World Health Organization (WHO), around 50 million people globally are living with epilepsy, making it one of the most common neurological disorders. Furthermore, the adoption of connected health technologies, integration of artificial intelligence for predictive analytics, and advancements in cloud-based monitoring platforms are significantly reshaping the industry landscape. Healthcare providers are actively shifting toward non-invasive and patient-friendly monitoring systems that not only capture critical data but also integrate seamlessly with electronic health records. However, challenges such as limited access to advanced neurological care in low-income countries, coupled with high costs associated with epilepsy monitoring devices, may restrain widespread adoption in certain regions over the forecast period.

Regionally, North America held the lion’s share of the market in 2024, a dominance attributed to its robust healthcare ecosystem, high awareness levels, and the presence of leading medical device manufacturers. The region benefits from favorable reimbursement policies, well-established neurology centers, and ongoing clinical research initiatives that further propel demand. Europe also represents a key contributor, with countries such as Germany, the UK, and France investing heavily in digital healthcare and neurological research programs. Meanwhile, the Asia Pacific region is projected to experience the fastest growth during 2025-2035, fueled by an increasing prevalence of epilepsy in densely populated nations like India and China, expanding healthcare access, and government-led initiatives aimed at modernizing healthcare infrastructure. The growing adoption of wearable monitoring technologies and mobile health solutions in Asia Pacific will play a pivotal role in driving market expansion.

Major market players included in this report are:
• Natus Medical Incorporated
• Nihon Kohden Corporation
• Koninklijke Philips N.V.
• Compumedics Limited
• Medtronic plc
• Masimo Corporation
• Boston Scientific Corporation
• Empatica Inc.
• NeuroPace, Inc.
• BioSerenity
• Cadwell Industries, Inc.
• Abbott Laboratories
• Neuronetrix Solutions, LLC
• LivaNova PLC
• Advanced Brain Monitoring, Inc.

Global Epilepsy Monitoring Devices Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period – 2025-2035
• Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players.

The detailed segments and sub-segments of the market are explained below:

By Product:
• Wearable Devices
• Conventional Devices

By End-use:
• Neurology Centers
• Diagnostic Centers

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico

Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with country-level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. Show more